Executive Directors | ||||||
---|---|---|---|---|---|---|
Chairman | CEO | JUNG HYUN HO | Male | CEO of Medy-tox | 2023.03.29 reappointed |
2026.03.29 terminate term |
- | Executive Directors | JU HEE SEOK | Male | CEO of NUMECO | 2023.03.29 reappointed |
2026.03.29 terminate term |
- | Executive Directors | SHIN HYO JIN | Male | CEO of Medytox Venture | 2022.03.31 appointed |
2025.03.30 terminate term |
Non- Executive Directors | ||||||
- | Non- Executive Directors | CHUNG DO HYUN | Male | Dominus Investment President CEO | 2023.03.29 appointed |
2026.03.29 terminate term |
- | Non- Executive Directors | OH JUNG MI | Female | Director of KACPE/Professor of College of Parmacy, SNU | 2023.03.29 appointed |
2026.03.29 terminate term |
Auditor | ||||||
- | Auditor | LEE YOUNG RAY | Male | Prev. Audit of Construction Gurantee | 2023.03.29 appointed |
2026.03.29 terminate term |
Date | Passed Y/N | Agenda | Executive Directors | Non- Executive Directors |
|||
---|---|---|---|---|---|---|---|
Jung Hyun Ho | Ju Hee Seok | Shin Hyo Jin | Chung Do Hyun | Oh Jung Mi | |||
2024.01.17 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | Pro | Pro |
Passed | Decision to issue of tresury stocks for the exercise of Stock Options | Pro | Pro | Pro | Pro | Pro | |
2024.01.19 | Passed | Investment in other companies | Pro | Pro | Pro | Pro | Pro |
2024.01.29 | Passed | Establishment of Compliance and Anti-Corruption System | Pro | Pro | Pro | Pro | Pro |
Passed | Report and approval of the establishment of a Health and Safety Plan | Pro | Pro | Pro | Pro | Pro | |
Passed | Revised Regulations on the Board of Directors | Pro | Pro | Pro | Pro | Pro | |
2024.02.29 | Passed | Revised Regulations on Internal Accounting Management system | Pro | Pro | Pro | Pro | Pro |
Passed | Report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro | Pro | Pro | |
Passed | Evaluation report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro | Pro | Pro | |
2024.03.07 | Passed | Approval of the 24th Financial Statement | Pro | Pro | Pro | Pro | Pro |
Passed | Decision to convene the 24th Regual Shareholders' Meeting | Pro | Pro | Pro | Pro | Pro | |
Passed | Implementation of Electronic Voting System for the 24th Regular Shareholders’ Meeting | Pro | Pro | Pro | Pro | Pro |
Date | Passed Y/N | Agenda | Executive Directors | Non- Executive Directors |
||
---|---|---|---|---|---|---|
Jung Hyun Ho | Ju Hee Seok | Shin Hyo Jin | Yoo Dong Hyun | |||
2023.01.27 | Passed | Report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro | Pro |
Passed | Evaluation report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro | Pro | |
2023.02.07 | Passed | Decision of Evolus stock disposal | Pro | Pro | Pro | - |
2023.03.07 | Passed | Approval of the 23rd Financial Statement | Pro | Pro | Pro | Pro |
2023.03.10 | Passed | Decision to convene the 23rd Regual Shareholders' Meeting | Pro | Pro | Pro | Pro |
Date | Passed Y/N | Agenda | Executive Directors | Non- Executive Directors |
|||
---|---|---|---|---|---|---|---|
Jung Hyun Ho | Ju Hee Seok | Shin Hyo Jin | Chung Do Hyun | Oh Jung Mi | |||
2023.03.29 | Passed | Appointment of the CEO | Pro | Pro | Pro | - | - |
2023.03.31 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | - | - |
2023.06.13 | Passed | Decision to issue of tresury stocks for the exercise of Stock Options | Pro | Pro | Pro | - | - |
2023.06.20 | Passed | Decision to sign a License Agreement of MBA-P01 | Pro | Pro | Pro | Pro | Pro |
2023.06.30 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | Pro | Pro |
2023.07.28 | Passed | Decision of Facility Loan | Pro | Pro | Pro | Pro | Pro |
2023.08.07 | Passed | Decision to repay new Loans and Operating funds | Pro | Pro | Pro | Pro | Pro |
2023.08.16 | Passed | Establishment of a local susidiary in U.S. | Pro | Pro | Pro | Pro | Pro |
2023.09.11 | Passed | Setting a base date for Quarterly Dividends | Pro | Pro | Pro | Pro | Pro |
2023.10.11 | Passed | Extention of Facility Loan | Pro | Pro | Pro | Pro | Pro |
Passed | Decision for Quarterly Cash Dividends | Pro | Pro | Pro | Pro | Pro | |
Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | Pro | Pro | |
2023.10.17 | Passed | Disposal of Investment Shares | Pro | Pro | Pro | Pro | Pro |
Passed | Decision to issue of tresury stocks for the exercise of Stock Options | Pro | Pro | Pro | Pro | Pro | |
2023.10.23 | Passed | New Loan of limited oprating funds | Pro | Pro | Pro | Pro | Pro |
2023.10.24 | Passed | Decision to withdraw New Drug Application(NDA) in China | Pro | Pro | Pro | Pro | Pro |
2023.10.31 | Passed | Report and approval of the establishment of a Health and Safety Plan | Pro | Pro | Pro | Pro | Pro |
2023.11.22 | Passed | Termination deal with Brazil Partner Company | Pro | Pro | Pro | Pro | Pro |
Date | Passed Y/N | Agenda | Executive Directors | Non- Executive Directors |
|
---|---|---|---|---|---|
Jung Hyun Ho | Ju Hee Seok | Yoo Dong Hyun | |||
2022.01.28 | Passed | Report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro |
Passed | Evaluation report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro | |
2022.02.18 | Passed | Decision to acquire Treasury Stock | Pro | Pro | Pro |
2022.03.10 | Passed | Report and approval of the establishment of a Health and Safety Plan | Pro | Pro | Pro |
2022.03.11 | Passed | Approval of the 22rd Financial Statement | Pro | Pro | Pro |
2022.03.15 | Passed | Decision to convene the 22rd Regual Shareholders' Meeting | Pro | Pro | Pro |
Date | Passed Y/N | Agenda | Executive Directors | Non- Executive Directors |
||
---|---|---|---|---|---|---|
Jung Hyun Ho | Ju Hee Seok | Shin Hyo Jin | Yoo Dong Hyun | |||
2022.03.31 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | Pro |
2022.04.01 | Passed | Revision of Internal Accounting Management Regualtions | Pro | Pro | Pro | Pro |
2022.04.29 | Passed | Establishment of Board Regulations | Pro | Pro | Pro | Pro |
2022.06.07 | Passed | Decision to acquire Treasury Stock | Pro | Pro | Pro | Pro |
2022.06.30 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | Pro |
2022.07.29 | Passed | Decision of overseas stock disposal | Pro | Pro | Pro | Pro |
2022.08.03 | Passed | Operating Fund Loan(KDB) | Pro | Pro | Pro | Pro |
2022.08.17 | Passed | Decision to acquire Treasury Stock | Pro | Pro | Pro | Pro |
2022.09.08 | Passed | Setting a base date for Quarterly Dividends | Pro | Pro | Pro | Pro |
2022.09.30 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | Pro |
2022.10.05 | Passed | Establishment of an overseas branch or office | Pro | Pro | Pro | Pro |
2022.10.14 | Passed | Decision for Quarterly Cash Dividends | Pro | Pro | Pro | Pro |
2022.12.12 | Passed | New Fund Loan | Pro | Pro | Pro | DNS |
Passed | Decision for Stock Devidends | Pro | Pro | Pro | Pro | |
2022.12.30 | Passed | Decision for Stock Devidends(corrected) | Pro | Pro | Pro | Pro |
Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | Pro |
Date | Passed Y/N | Agenda | Executive Directors | Non- Executive Directors |
||
---|---|---|---|---|---|---|
Jung Hyun Ho | 양기혁 | Ju Hee Seok | Yoo Dong Hyun | |||
2021.01.18 | Passed | Costs of Lawyers in criminal cases | Pro | Pro | Pro | DNS |
2021.01.29 | Passed | Costs of Lawyers in criminal cases | Pro | Pro | Pro | DNS |
Passed | Report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro | Pro | |
Passed | Evaluation report on the operation status of the Internal Accounting Management System | Pro | Pro | Pro | Pro | |
2021.02.19 | Passed | Bilateral Agreement with EVOLUS | Pro | Pro | Pro | DNS |
Passed | Three-way Agreement between ALLERGAN, EVOLUS and MEDY-TOX | Pro | Pro | Pro | DNS | |
Passed | Other key contract details | Pro | Pro | Pro | DNS | |
2021.02.26 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | DNS |
2021.03.04 | Passed | Introduction of Electornic Voting System at Regual Shareholders' Meeting | Pro | Pro | Pro | DNS |
2021.03.10 | Passed | Report and approval of the establishment of a Health and Safety Plan | Pro | Pro | Pro | DNS |
2021.03.12 | Passed | Approval of the 21rd Financial Statement | Pro | Pro | Pro | Pro |
2021.03.15 | Passed | Decision to convene the 21rd Regual Shareholders' Meeting | Pro | Pro | Pro | Pro |
2021.03.24 | Passed | Decision to convene the General Meeting of a Specifi Class of Shareholders | Pro | Pro | Pro | Pro |
2021.03.31 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | DNS |
2021.04.08 | Passed | Issuance of Redeemable Covertible Preferred Stocks | Pro | Pro | Pro | DNS |
Passed | Conclusion of a contract to acquire Redeemable Covertible Preferred Stocks | Pro | Pro | Pro | DNS | |
2021.04.20 | Passed | Confirmation of conditions for issuance of Redeemable Covertible Preferred Stock | Pro | Pro | Pro | DNS |
2021.04.26 | Passed | Investments to Centenaire Bioscience | Pro | - | Pro | Pro |
2021.04.27 | Passed | Establishment of a local susidiary in Thailand | Pro | Pro | Pro | DNS |
Passed | Approval of concurrent position of realted company | Pro | Pro | Pro | DNS | |
2021.04.30 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro | DNS |
2021.06.22 | Passed | Signing a License Agreement with AEON Biopharma | Pro | Pro | Pro | DNS |
2021.06.28 | Passed | Compensation for Retirement | Pro | Pro | Pro | DNS |
Date | Passed Y/N | Agenda | Executive Directors | Non- Executive Directors |
|
---|---|---|---|---|---|
Jung Hyun Ho | Ju Hee Seok | Yoo Dong Hyun | |||
2021.07.26 | Passed | Operating Fund Loan(Hana Bank) | Pro | Pro | Pro |
2021.07.27 | Passed | Operating Fund Loan(KDB) | Pro | Pro | Pro |
2021.08.05 | Passed | Decision of overseas stock acquisition | Pro | Pro | Pro |
2021.08.06 | Passed | Investments and License Agreement to Liveome Inc. | Pro | Pro | Pro |
2021.09.08 | Passed | Return of rights of improved neurotoxing candiate(MT10109L) and Contract Termination with Abbvie | Pro | Pro | DNS |
2021.09.30 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | DNS |
2021.10.14 | Passed | Decision to capital increase by issuing new shares of Liviom | Pro | Pro | Pro |
2021.10.15 | Passed | Decision to capital increase by issuing new shares of Centenaire Bioscience | Pro | Pro | Pro |
2021.10.21 | Passed | Decision to acquire Treasury Stock | Pro | Pro | Pro |
2021.12.01 | Passed | Decision for Stock Devidends | Pro | Pro | Pro |
2021.12.09 | Passed | New Fund Loan | Pro | Pro | Pro |
2021.12.31 | Passed | Cancellation of the Stock Option Grant | Pro | Pro | Pro |